alexa Structure Activity Relationship (SAR) of Some Benzoic Acid Derivatives from Plant Origin that Exhibit Anti-Sickling Properties in vitro - (Review) | Open Access Journals
ISSN: 2329-6836
Natural Products Chemistry & Research
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Structure Activity Relationship (SAR) of Some Benzoic Acid Derivatives from Plant Origin that Exhibit Anti-Sickling Properties in vitro - (Review)

Luhata Lokadi Pierre1*, Namboole Munkombwe Moses2 and Cheuka Mubanga Peter3
1Laboratoire de Phytochimie et contrôle qualité, ISAV-Kimwenza, 3724, Kinshasa, The Democratic Republic of Congo (DRC)
2Department of Chemistry, University of Zambia, 32379, Lusaka, Zambia
3Department of Chemistry, University of Cape Town, Rondebosch, 7701, South Africa
Corresponding Author : Luhata Lokadi Pierre
Directeur du Laboratoire de Phytochimie/Institut
Supérieur Agrovétérinaire/Saint Pierre Canisius-Kimwenza
Kinshasa, The Democratic Republic of Congo (DRC)
Tel: +243972056914
E-mail: [email protected]
Received May 05, 2015; Accepted May 05, 2015; Published May 13, 2015
Citation: Pierre LL, Moses NM, Peter CM (2015) Structure Activity Relationship (SAR) of Some Benzoic Acid Derivatives from Plant Origin that Exhibit Anti-Sickling Properties in vitro - (Review). Nat Prod Chem Res 3:176. doi: 10.4172/2329-6836.1000176
Copyright: © 2015 Pierre LL, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Related article at
DownloadPubmed DownloadScholar Google

Visit for more related articles at Natural Products Chemistry & Research


Anemia or sickle cell disease (SCD) affects millions of people worldwide, mainly in Africa. Strategies to treat sickle cell anemia still focus on prophylactic measures to alleviate the painful crises and prevent adverse effects. Medicinal plants are commonly used in Africa and Asia in the management of SCD. These herbs contain some phytochemicals which exhibit anti-sickling properties in vitro. Benzoic acid derivatives (BADs) seem to play a key role in the bioactivity observed. A combination of medicinal plants containing BADs, amino acids, antioxidant compounds and some minerals could be the best option in designing a phytomedicine against SCD. Justimovi, a food made using the same rationale, is a promising and potent phytomedicine for people suffering from anemia.

Sickle cell disease; BADs; Aminoacids; Anti-oxidants; Justimovi; Phytomedicine
Sickle cell disease (SCD) is a hereditary blood disorder arising from the replacement of a polar amino acid residue (glutamic acid) by a nonpolar one (valine) at the sixth position of the β-chain of haemoglobin. At low oxygen tension, the sickle haemoglobin polymerises inside the red blood cell into a gel or further into fibers leading to a drastic increase in the red cell deformability [1,2]. As a result, micro-vascular occlusion arises which can often be fatal [3]. SCD is associated with a number of acute and chronic health problems, such as severe infections, attacks of severe pain ("sickle-cell crisis"), and stroke, with an increased risk of death.
About 300,000 children are born with a form of SCD every year. In 2013, more deaths, 176,000, were recorded compared to 113,000 deaths reported in 1990 [4]. According to reports, Africa is an endemic region of SCD and those afflicated with the disease are estimated at 200,000 per year [5]. The carrier frequency ranges between 10 and 40% across equatorial Africa, decreasing to 1–2% on the North African coast and <1% in South Africa [6].
Due to the high cost of managing SCD, research has been on-going on the exploration of medicinal plants to address the multiple health challenges presented by the disease [7]. To prevent polymerization of haemoglobin and vascular occlusions, extracts of medicinal plants have been used in folk medicine in the management of SCD. The observed therapeutic effect of these herbs may be as a result of combined antisickling, anti-polymerization, anti-dehydration, anti-inflammatory and antioxidant effects from the components of the plants, which is typical of most herbal remedies.
Benzoic Acid Derivatives (BADS) and Anti-Sickling Properties
In 1971, Sofowora and his colleagues worked on the root extract of Fagara xanthoxyloides and discovered that the benzoic acid derivatives (BADs) exhibit anti-sickling properties in vitro (Figures 1 and 2). 3,5-Dimethoxy-4-hydroxybenzoic acid or Protocatechuic acid, p-hydroxy- benzoic acid, vanillic acid, syringic acid and ferulic acid were tested in vitro and their anti-sickling properties were confirmed [8,9]. P-Hydroxy-benzoic acid has also been reported to have antibacterial (against Gram positive and negative bacteria), antifungal, anti-algal, antimutagenic and estrogenic activity [10]. Vanillin is known to inhibit gelation of haemoglobin and markedly increases oxygen affinity of both normal (HbA) and abnormal (HbS) haemoglobin [11,12]). The anti-sickling properties of p-fluorobenzoic acid have been reported by Elekwa and his colleagues [13]. Burkinabin C, a divanilloylquinic acid found in the root bark of Fagara zanthoxyloides, exhibited anti-sickling properties in vitro (Badioré O, et al.). Ferulic acid is a hydroxycinnamic acid, a type of organic compound. Aromatic aldehydes form Schiff bases with haemoglobin and were designed as potential anti-sickling agents as they reduce the ability of HbS to polymerise on deoxygenation [11,12]. Ferulic acid, like many natural phenols, is an antioxidant in vitro in the sense that it is reactive toward free radicals such as reactive oxygen species (ROS). Its anti-sickling properties were established by [14].
Biosynthesis of BADs
Many aromatic compounds, particularly BADs and the aromatic amino acids L-phenylalanine, L-tyrosine and L-tryptophan are synthesized through the shikimate pathway. A central intermediate in the pathway is shikimic acid (SKA), a compound which had been isolated from plants of Illicium species ‘Japanese‘shikimi’.
Diverse biochemical reactions take place during the biosynthesis of SKA namely: aldol-type condensation, hydrolysis, eliminations, phosphorylations, oxidations and reductions reactions using Nicotinamide Adenine Dinucleotide (NAD+), Nicotinamide adenine dinucleotide phosphate (NADH), Adenosine Triphosphate (ATP) and enzymes. Among the aromatic compounds synthesized via shikimate pathway are 4-hydroxybenzoic acid, salicylic acid, p-amino benzoic acid (PABA) which forms part of the structure of folic acid (vitamin B9) a molecule used in the management of SCD. Folic acid (Figure 3) is found in yeast, liver, and green vegetables. It is a thermodegradable compound. Though cooking may destroy up to 90% of the vitamin.
Salicin (Salix species; Salicaceae) is responsible for the analgesic and antipyretic effects of willow barks, widely used for centuries, and the template for synthesis of acetylsalicylic acid (aspirin) as a more effective analogue. Chemically, Aspirin has a similar core structure as Salicin or salicylic acid which is synthesized in microorganisms from isochorismic acid and in plants by two other mechanisms: hydroxylation of benzoic acid (Figure 4) or by side-chain cleavage of 2-coumaric acid, which itself is formed by an ortho-hydroxylation of cinnamic acid.
Mode of Action of Aspirin and NSAIDs
According to Goodman and Gilman, all non-steroidal antiinflammatory drugs (NSAIDs), including the traditional nonselective drugs and the subclass of selective cyclooxygenase-2 (COX-2) inhibitors, are anti-inflammatory, analgesic, and anti-pyretic. NSAIDs are a chemically heterogeneous group of organic acids that share certain therapeutic actions and adverse effects.
The similarities observed in structure can explain why these compounds share the same bioactive properties. The acetyl-3,5- dibromosalicylic acid (dibromo aspirin), a derivative of aspirin, has been reported to exhibit the erythrocyte sickling [15]. Acetylation of hemoglobin by aspirin and other acetylating agents has been used to generate haemoglobin analogs with altered structural and functional properties, and may prove useful in the treatment of sickle cell disease [16].
Aspirin inhibits the COX enzymes but in a manner molecularly distinct from the competitive, reversible, active site inhibitors and is often distinguished from the NSAIDs. In fact, Aspirin and tNSAIDs inhibit the biosynthesis of Prostaglandins in all cell types whenever cells are damaged.
Structure Activity Relationship of BADs
Understanding of the structural features that are crucial to antisickling activity of anti-sickling agents is critically important in the design of new chemical entities to treat and/or cure SCD. In this regard, a number of structure activity relationship studies employing both in silico and experimental techniques have been reported. In this review, we focus on SAR studies around antisickling agents possessing a benzoic acid core scaffold and other related derivatives.
Mathematical modeling techniques have been employed in predicting the antisickling activities of benzoic acid derivatives. Employing such mathematical modeling approaches, Fasanmade et al. [17] were able to derive a quantitative structure activity relationship from a series of synthetic benzoic acid derivatives. Derivatives predicted to be active by the mathematical model were tested experimentally and these included p-toluic acid, p-dimethylaminobenzoic acid, p-fluorobenzoic acid, p-chlorobenzoic acid, m-chlorobenzoic acid, p-bromobenzoic acid, p-nitrobenzoic acid, and p-iodobenzoic acid (Figures 5-7).
The anti-sickling activities (the ability to induce normal morphology to deoxygenated and sickle-shaped red blood cells) of these benzoic acid derivatives were predicted by the Hansch lipophilicity pi (π) and the Hammett electronic sigma (σ) constants. After analyzing a series of equations correlating biological activities with the structures of the tested derivatives, Fasanmade et al. [17] concluded: strong electron donating groups attached on the benzene ring with average lipophilicity are an important feature for such benzoic acid derivatives to possess potent antisickling activity.
Other studies have also revealed promising antisickling activity of benzoic acid derivatives. In 1984, Abraham et al. reported the design, synthesis, and anti-sickling evaluation of disubstituted benzoic acids [18]. The designing of the disubstituted benzoic acid derivatives involved the use of molecular modeling techniques. Such a design ensured the strategic positioning of functional groups to facilitate their interaction with several polar amino acid residues near the Valine-6 beta mutation site in sickled haemoglobin (HbS). A hydrophobic group (the phenyl core) was also rationally incorporated to occupy a nonpolar area on the surface of the protein created by several hydrophobic amino acids. Synthesis and antigelling evaluation of these rationally designed target compounds gave rise to derivatives with promising antisickling activities. For structural details of such compounds, the reader is referred to the original research article [18].
From such studies, therefore, it appears two structural features are crucial to potent activity of anti-sickling chemotherapeutic agents. Firstly, hydrophilic substituents on the phenyl ring are necessary to facilitate interaction and binding to polar amino acid residues near the mutation site. Secondly, a phenyl core is critically important to enhance hydrophobic interactions with several hydrophobic amino acids. The aromatic moiety seems to play an important role in the bioactivity of BADs. The sp2 hybridized carbons make these molecules planar, a characteristic that facilitates binding to drug target binding pockets. This results in anti-inflammatory, analgesic, and antipyretic activity. It has been proposed that the pi (π) electronic system present in alkynes and aromatic rings are regions of high electron density and can act as hydrogen bond acceptors. [19].
The carboxylic groups attached to the phenyl ring are moderate hydrogen bond acceptors/donors. Furthermore, ethers, alcohols, phenols, amides, amines and ketones act as hydrogen bond acceptors and/or donors. These groups can in vivo form moderately strong hydrogen bonds, therefore, conferring potent bioactivity.
Management of Sickle Cell Disease Using Medicinal Plants
Plants produce a large number of molecules which can be used in the management of SCD. In most parts of developing countries, medicinal plants have been used in the treatment of painful crises associated with SCD, especially among the lower socio-economic class who cannot afford the high cost of western medicine [20].
A number of plants used in traditional medicine have been investigated. Some of them exhibited anti-sickling properties in vitro. These include Piper guineensis, Pterocarpa osun, Eugenia caryophyllala and Sorghum bicolor [21]; Fagara zanthoxyloides [22]; Cajanus cajan [23]; Vigna unguiculata [24]; Carica papaya [25,26]; and Justicia secunda ([27,28].
The phytochemistry of these plants reveals the presence of BADs, amino acids, anti-oxidants, alkaloids, minerals etc. Phenolic and polyphenolics are known to possess excellent anti-oxidant activities, and may play a significant role in SCD management. Phenylalanine particularly has been found to be a potent inhibitor of HbS gelation and acts by competing for the protein-protein contact sites within the HbS polymer, which may also be the mechanism of action of other antisickling amino acids and peptides [29].
A combination of vegetables and foods which are rich in BADs, amino acids, and anti-oxidants can be prescribed as phytomedicines to people suffering from SCD. Using the same rationale, the Laboratoire de phytochimie/Isav-kimwenza has made a food (JUSTIMOVI) which possesses the properties of reducing vasocclusive crises and attacks of severe pain.
SCD remains a big challenge for researchers. New research efforts and approaches in the management of this blood disorder are ongoing. Some of these treatment options are very expensive and beyond the reach of many. To overcome this problem, scientific investigations have proved the necessity of incorporating medicinal plants in the management of SCD. The analgesic, antipyretic, and anti-sickling properties of BADs seem to be important in designing a potent phytomedicine. BADs, amino-acids, anti-oxidants, and some minerals (K, Mg, Ca, Fe) together can improve the quality of health for people suffering from SCD. On the basis of phytochemistry and pharmacology studies, Justimovi is an example of phytomedicine against anemia.
We are very grateful to De la Kethulle Henri, Sj, Michel N’tangu, Sj and the Croisade Nationale Drépanocytose (CND) for the financial support.

Figures at a glance

image   image   image   image
Figure 1   Figure 2   Figure 3   Figure 4
image   image   image
Figure 5   Figure 6   Figure 7
Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Relevant Topics

Recommended Conferences

Article Usage

  • Total views: 12379
  • [From(publication date):
    May-2015 - Aug 19, 2017]
  • Breakdown by view type
  • HTML page views : 8458
  • PDF downloads :3921

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version